Di Nunno, VincenzoMassari, FrancescoMollica, VeronicaCimadamore, AlessiaSantoni, MatteoCheng, LiangLopez-Beltran, AntonioScarpelli, MarinaMontironi, Rodolfo2020-02-242020-02-242019-07Di Nunno, V., Massari, F., Mollica, V., Cimadamore, A., Santoni, M., Cheng, L., Lopez-Beltran, A., Scarpelli, M., & Montironi, R. (2019). Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma. Annals of translational medicine, 7(Suppl 3), S137. https://doi.org/10.21037/atm.2019.06.06https://hdl.handle.net/1805/22114en-USPublisher PolicyNon-Clear Cell Renal Cell CarcinomaUncommon DiagnosesInterventional studiesCabozantinibTyrosine Kinase InhibitorImmunotherapyAnother one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinomaArticle